Robert Rae, MD
Internal Medicine · Sylvania, OHNPI 1003852070
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $183,570 of the $183,707 with a category attached, or 99.9%. CSL Behring accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $62,205 and has fallen 100.0% since, to $18 in 2023. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 175 payments — averaging $1049.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$184K
- Shockwave Medical, Inc$119
- Eisai Inc.$18
What the payments were for
- Consulting fees$183,570100%
- Food & beverage$1370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 173 | $183,570 |
| Shockwave Medical, Inc | 1 | $119 |
| Eisai Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$183,707 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rasagiline Mesylate | 11 | $4,777 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 36 | $495 |
| Divalproex Sodium | 36 | $474 |
| Atorvastatin Calcium | 48 | $350 |
| Dicyclomine Hcl | 14 | $222 |
| Metoprolol Succinate | 11 | $92 |
| Famotidine | 11 | $54 |
| Amlodipine Besylate | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Sylvania
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.